Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$175M |
| 2 |
Intel
INTC
|
+$154M |
| 3 |
Amazon
AMZN
|
+$115M |
| 4 |
IBM
IBM
|
+$97.2M |
| 5 |
Prologis
PLD
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
GGP
GGP Inc.
GGP
|
+$135M |
| 3 |
TSMC
TSM
|
+$111M |
| 4 |
DCT
DCT Industrial Trust Inc.
DCT
|
+$81.8M |
| 5 |
XL
XL Group Ltd.
XL
|
+$59.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.59% |
| 2 | Financials | 14.04% |
| 3 | Healthcare | 13.2% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Compañía de Minas Buenaventura
BVN
$8.55B
| $3.52M | ﹤0.01% |
262,158
+5,431
| +2% | +$70.6K |
|
2227
Select Water Solutions
WTTR
$2.63B
| $3.51M | ﹤0.01% |
296,388
+199,834
| +207% | +$2.75M |
|
|
DRNA
2228
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.51M | ﹤0.01% |
229,930
+140,430
| +157% | +$2.04M |
|
|
HK
2229
DELISTED
Halcon Resources Corporation
HK
| $3.5M | ﹤0.01% |
782,606
+8,091
| +1% | +$33.9K |
|
2230
Mesa Laboratories
MLAB
$633M
| $3.5M | ﹤0.01% |
18,831
+1,578
| +9% | +$318K |
|
2231
Solid Biosciences
SLDB
$974M
| $3.49M | ﹤0.01% |
4,927
+2,393
| +94% | +$1.5M |
|
2232
CEVA Inc
CEVA
$855M
| $3.49M | ﹤0.01% |
121,252
+4,664
| +4% | +$141K |
|
2233
Ecovyst
ECVT
$1.1B
| $3.48M | ﹤0.01% |
199,109
+35,409
| +22% | +$627K |
|
2234
Anika Therapeutics
ANIK
$283M
| $3.47M | ﹤0.01% |
82,343
+3,414
| +4% | +$135K |
|
2235
Axcelis
ACLS
$4.42B
| $3.47M | ﹤0.01% |
176,426
+5,250
| +3% | +$108K |
|
2236
Accuray
ARAY
$32.9M
| $3.46M | ﹤0.01% |
769,332
+237,137
| +45% | +$935K |
|
|
NXRT
2237
NexPoint Residential Trust
NXRT
$636M
| $3.44M | ﹤0.01% |
103,756
+66,766
| +180% | +$2.06M |
|
|
FLXN
2238
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.44M | ﹤0.01% |
183,769
+4,111
| +2% | +$94.5K |
|
|
APLS
2239
DELISTED
Apellis Pharmaceuticals
APLS
| $3.42M | ﹤0.01% |
192,559
+20,380
| +12% | +$377K |
|
2240
Peoples Bancorp
PEBO
$1.49B
| $3.41M | ﹤0.01% |
97,415
-892
| -0.9% | -$32.8K |
|
|
EVRI
2241
DELISTED
Everi Holdings
EVRI
| $3.4M | ﹤0.01% |
371,314
+35,627
| +11% | +$292K |
|
|
BRFS
2242
DELISTED
BRF SA
BRFS
| $3.38M | ﹤0.01% |
616,675
+5,474
| +0.9% | +$30.4K |
|
2243
WillScot Mobile Mini Holdings
WSC
$4.17B
| $3.37M | ﹤0.01% |
196,250
+17,602
| +10% | +$288K |
|
|
ORIT
2244
DELISTED
Oritani Financial Corp. New
ORIT
| $3.36M | ﹤0.01% |
215,829
+10,104
| +5% | +$163K |
|
2245
LeMaitre Vascular
LMAT
$1.87B
| $3.36M | ﹤0.01% |
86,606
+6,950
| +9% | +$250K |
|
|
WRD
2246
DELISTED
WildHorse Resource Development
WRD
| $3.33M | ﹤0.01% |
140,637
+17,668
| +14% | +$379K |
|
|
PFC
2247
DELISTED
Premier Financial Corp. Common Stock
PFC
| $3.32M | ﹤0.01% |
110,387
+67,343
| +156% | +$2.17M |
|
|
AXDX
2248
DELISTED
Accelerate Diagnostics
AXDX
| $3.32M | ﹤0.01% |
14,457
+984
| +7% | +$218K |
|
2249
Flex
FLEX
$45.9B
| $3.31M | ﹤0.01% |
334,669
+48,841
| +17% | +$511K |
|
2250
Entravision Communication
EVC
$820M
| $3.3M | ﹤0.01% |
672,491
+155
| +0% | +$774 |
|
Similar funds
Charles Schwab's Q3 2018 Portfolio in Review
As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $156M trimmed.
- Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
- Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
- Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
- Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
- Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
- Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.
Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.